Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Vial

Showing results (161-170 of 168) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 168 results.
Veterinary Journal (London, England : 1997)|April 5, 2024
Description of serum symmetric dimethylarginine concentration and of urinary SDS-AGE pattern in dogs with ACTH dependent hyperadrenocorticismM Menard, M Kurtz, A Duclos, et al.
The Journal of Antimicrobial Chemotherapy|November 17, 2010
Symmetrical choline-derived dications display strong anti-kinetoplastid activityHasan M S Ibrahim, Mohammed I Al-Salabi, Nasser El Sabbagh, et al.
Journal De Radiologie|June 28, 2011
[Evolution of the pelvis and hip throughout history: from primates to modern man]F Lapègue, M Jirari, S Sethoum, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|February 1, 1990
Phospholipid asymmetry in the plasma membrane of malaria infected erythrocytesG N Moll, H J Vial, E M Bevers, et al.
Biochimica Et Biophysica Acta|May 9, 1990
Selective elimination of malaria infected erythrocytes by a modified phospholipase A2 in vitroG N Moll, H J Vial, F C van der Wiele, et al.
Nature Communications|February 1, 2017
SC83288 is a clinical development candidate for the treatment of severe malariaStefano Pegoraro, Maëlle Duffey, Thomas D Otto, et al.
Nature Communications|April 7, 2017
Erratum: SC83288 is a clinical development candidate for the treatment of severe malariaStefano Pegoraro, Maëlle Duffey, Thomas D Otto, et al.
Cell Death Discovery|July 31, 2020
Low expression of ANT1 confers oncogenic properties to rhabdomyosarcoma tumor cells by modulating metabolism and death pathwaysJ Vial, P Huchedé, S Fagault, et al.
Pageof 17

Showing results (161-170 of 168) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
Veterinary Journal (London, England : 1997)|April 5, 2024
Description of serum symmetric dimethylarginine concentration and of urinary SDS-AGE pattern in dogs with ACTH dependent hyperadrenocorticismM Menard, M Kurtz, A Duclos, et al.
The Journal of Antimicrobial Chemotherapy|November 17, 2010
Symmetrical choline-derived dications display strong anti-kinetoplastid activityHasan M S Ibrahim, Mohammed I Al-Salabi, Nasser El Sabbagh, et al.
Journal De Radiologie|June 28, 2011
[Evolution of the pelvis and hip throughout history: from primates to modern man]F Lapègue, M Jirari, S Sethoum, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|February 1, 1990
Phospholipid asymmetry in the plasma membrane of malaria infected erythrocytesG N Moll, H J Vial, E M Bevers, et al.
Biochimica Et Biophysica Acta|May 9, 1990
Selective elimination of malaria infected erythrocytes by a modified phospholipase A2 in vitroG N Moll, H J Vial, F C van der Wiele, et al.
Nature Communications|February 1, 2017
SC83288 is a clinical development candidate for the treatment of severe malariaStefano Pegoraro, Maëlle Duffey, Thomas D Otto, et al.
Nature Communications|April 7, 2017
Erratum: SC83288 is a clinical development candidate for the treatment of severe malariaStefano Pegoraro, Maëlle Duffey, Thomas D Otto, et al.
Cell Death Discovery|July 31, 2020
Low expression of ANT1 confers oncogenic properties to rhabdomyosarcoma tumor cells by modulating metabolism and death pathwaysJ Vial, P Huchedé, S Fagault, et al.
Pageof 17